House dust mites allergen extract - Allergic rhinitis
You are here : Home > Formulary Search > House dust mites allergen extract - Allergic rhinitis
Status 1
- Oral lyophilisates
As per NICE TA - for treating moderate to severe house dust mite allergic rhinitis in people 12 to 65 years
To be initiated at specialist allergy clinics only (locally at ASPH & RSFT) with at least 3 months prescribing before transfer to primary care.
Documentation
PAD Profile
Other Indications
Below are listed other indications that House dust mites allergen extract is used to treat.
Other Drugs
Below are listed other drugs that are used to treat Allergic rhinitis.
- Acrivastine
- Azelastine hydrochloride
- Beclometasone dipropionate
- Bilastine
- Budesonide
- Cetirizine hydrochloride
- Chlorphenamine maleate
- Desloratadine
- Fexofenadine hydrochloride
- Fluticasone furoate
- Fluticasone propionate (Nasal)
- Fluticasone with azelastine
- Ipratropium bromide
- Ketotifen fumarate
- Levocetirizine
- Loratadine
- Mizolastine
- Mometasone furoate
- Mometasone furoate with olopatadine
- Promethazine hydrochloride
- Rupatadine fumarate
- Triamcinolone acetonide
- White Birch pollen allergen extract
Committee Recommendations (1)
The Surrey Heartlands Integrated Care System Area Prescribing Committee (APC) approves Acarizax (12 SQ-HDM SLIT) for treating allergic rhinitis caused by house dust mites in line with NICE TA1045.
A BLUE (with specialist initiation) traffic light status has been agreed with at least 3 months prescribing by the specialist team to enable review and confirmation of clinical benefit, prior to transfer of care to Primary Care